Newsroom
Category
September 10, 2019
UT Health San Antonio researchers have discovered a novel way to kill cancers that are caused by an inherited mutation in BRCA1, the type of cancer for which actress Angelina Jolie had preventive double mastectomy and reconstructive surgery in 2013. “This represents a new treatment for inherited breast and ovarian cancer, which are higher in […]
September 10, 2019
The U.S. Food and Drug Administration recently approved the first new medication in nearly a decade for patients with myelofibrosis, a rare blood cancer. Ruben Mesa, M.D., FACP, director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was part of the international research team that led development of […]
September 4, 2019
September is Women in Medicine Month. Read about the achievements and talents of some of UT Health San Antonio’s women faculty in the first in a series of newsletters. View the newsletter
August 28, 2019
The largest award, $892,157, went to Yidong Chen, Ph.D., a professor of population health sciences in the Joe R. and Teresa Lozano Long School of Medicine.
August 20, 2019
Daruka Mahadevan, M.D., Ph.D., will also lead the hematology and medical oncology service line within the Mays Cancer Center.
August 19, 2019
The St. Baldrick’s Foundation has awarded $306,000 to David Libich, Ph.D., of UT Health San Antonio to further his studies of the childhood cancer Ewing sarcoma.